345 related articles for article (PubMed ID: 20620535)
21. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
22. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
23. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
24. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
[TBL] [Abstract][Full Text] [Related]
26. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
[TBL] [Abstract][Full Text] [Related]
27. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.
Akı SZ; Paşaoğlu H; Yeğin ZA; Suyanı E; Demirtaş CY; Ozkurt ZN; Yağcı M; Sucak GT
Hematology; 2011 Sep; 16(5):284-90. PubMed ID: 21902892
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of iron parameters in patients undergoing allo-SCT.
Bazuaye GN; Buser A; Gerull S; Tichelli A; Stern M
Bone Marrow Transplant; 2012 Jan; 47(1):60-4. PubMed ID: 21399668
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.
Aki ZS; Sucak GT; Yeğin ZA; Güzel O; Erbaş G; Senol E
Transplant Proc; 2008 Jun; 40(5):1579-85. PubMed ID: 18589155
[TBL] [Abstract][Full Text] [Related]
31. Iron Overload in Survivors of Childhood Cancer.
Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
[TBL] [Abstract][Full Text] [Related]
32. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
33. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
35. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
[TBL] [Abstract][Full Text] [Related]
36. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
[TBL] [Abstract][Full Text] [Related]
37. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
[TBL] [Abstract][Full Text] [Related]
39. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
[TBL] [Abstract][Full Text] [Related]
40. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
